ARD1B
- Known as:
- ARD1B
- Catalog number:
- 001834A
- Product Quantity:
- 250ul
- Category:
- -
- Supplier:
- ABM
- Gene target:
- ARD1B
Related genes to: ARD1B
- Gene:
- NAA11 NIH gene
- Name:
- N(alpha)-acetyltransferase 11, NatA catalytic subunit
- Previous symbol:
- ARD1B
- Synonyms:
- ARD2, hARD2
- Chromosome:
- 4q21.21
- Locus Type:
- gene with protein product
- Date approved:
- 2005-04-08
- Date modifiied:
- 2017-12-15
Related products to: ARD1B
Ard1b (Center) antibody Host rabbitArd1b antibodyARD1B antibodyArd1b AntibodyArd1b antibody - middle region (ARP48601_P050)Ard1b antibody, Purified Polyclonal Antibodies, Host RabbitArd1b Blocking PeptideArd1b Blocking Peptide, Blocking PeptidesARD1B siRNA_LentivectorsARD1B siRNA_LentivectorsARD1B siRNA_LentivectorsARD1B siRNA_LentivectorsARD1B,ARD2,hARD2,Homo sapiens,Human,NAA11,N-alpha-acetyltransferase 11,NatA catalytic subunit,N-terminal acetyltransferase complex ARD1 subunit homolog BArd1b,Ard2,Mouse,Mus musculus,Naa11,N-alpha-acetyltransferase 11,NatA catalytic subunit,N-terminal acetyltransferase complex ARD1 subunit homolog BArd1b,Ard2,Naa11,N-alpha-acetyltransferase 11,NatA catalytic subunit,N-terminal acetyltransferase complex ARD1 subunit homolog B,Rat,Rattus norvegicus Related articles to: ARD1B
- Astrocytoma is the most common glioma, accounting for about 65% of glioblastoma. Its malignant transformation is also one of the important causes of patient mortality, making it the most prevalent and difficult to treat in primary brain tumours. However, little is known about the underlying mechanisms of this transformation. - Source: PubMed
Cui YaqianZheng HongquanZhou ZhengweiLiu SuoShen MingxueQiu RunzeZhang XiongLi YingbinFan Hongwei - Autism is a severe neurodevelopmental disorder characterized by social interaction deficits, impairments in communication, and restricted and repetitive stereotyped behavior and activities. Family and twin studies suggested an essential role of genetic factors in the etiology of autism spectrum disorder (ASD). Also, other studies found and () might be involved in brain development and susceptible to ASD. - Source: PubMed
Publication date: 2023/12/22
Lin FenJun Li Ziqi Wang Zhang TianLu TianlanJiang MiaomiaoYang KangJia MeixiangZhang DaiWang Lifang - This study presents the draft genome sequences of four strains of rhizobacteria, namely, Bacillus cereus ADO11, Stenotrophomonas maltophilia NAA11, Acinetobacter pittii LAM11, and Serratia marcescens NSA15, which were isolated from maize soils and have the ability to stimulate plant growth. The genome assembly sizes for the strains were 4,476,462 bp, 4,731,402 bp, 4,080,875 bp and 4,959,744 bp, respectively. - Source: PubMed
Publication date: 2022/10/18
Babalola Olubukola OlurantiAgbodjato Nadège AdoukèAyangbenro Ayansina SegunAdjanohoun AdolpheBaba-Moussa Lamine - To determine the role of RNA-binding protein with serine-rich domain 1 (RNPS1) in uterine corpus endometrial carcinoma (UCEC), the role of RNPS1 knockdown in UCEC development in vitro and in vivo, and the relationship between RNPS1 and mismatch repair (MMR) in UCEC. - Source: PubMed
Publication date: 2021/11/19
Liu XiaojuanMa HuiMa LishaLi KunKang Yanhua - N-terminal acetylation (Nt-Ac) is an abundant eukaryotic protein modification, deposited in humans by one of seven N-terminal acetyltransferase (NAT) complexes composed of a catalytic and potentially auxiliary subunits. The involvement of NATs in cancers is being increasingly recognised, but a systematic cross-tumour assessment is currently lacking. To address this limitation, we conducted here a multi-omic data interrogation for NATs. We found that tumour genomic alterations of NATs or of their protein substrates are generally rare events, with some tumour-specific exceptions. In contrast, altered gene expression of NATs in cancers and their association with patient survival constitute a widespread cancer phenomenon. Examination of dependency screens revealed that (i), besides NAA60 and NAA80 and the NatA paralogues NAA11 and NAA16, the other ten NAT genes were within the top 80th percentile of the most dependent genes (ii); NATs act through distinct biological processes. NAA40 (NatD) emerged as a NAT with particularly interesting cancer biology and therapeutic potential, especially in liver cancer where a novel oncogenic role was supported by its increased expression in multiple studies and its association with patient survival. In conclusion, this study generated insights and data that will be of great assistance in guiding further research into the function and therapeutic potential of NATs in cancer. - Source: PubMed
Publication date: 2020/09/15
Koufaris CostasKirmizis Antonis